ClinConnect ClinConnect Logo
Search / Trial NCT05496881

Exercise Effects in Multiple Sclerosis

Launched by UNIVERSITY OF REGINA · Aug 8, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Progressive Multiple Sclerosis Relapsing Remitting Multiple Sclerosis Central Nervous System Motor Learning Transcranial Magnetic Stimulation Mobility Limitation

ClinConnect Summary

This clinical trial is exploring how different types of exercise can impact people living with multiple sclerosis (MS). Researchers want to understand how regular exercise might help manage symptoms, improve physical function, and affect the brain and nervous system in individuals with various forms of MS, including progressive and relapsing types. This study will be the first to compare the effects of different exercise routines on the central nervous system for those with MS.

To participate, individuals must be diagnosed with progressive MS by a neurologist and receive a doctor's approval to exercise. They should have a moderate level of motor disability, which is measured by a specific scoring system. Participants should be aged between 65 and 74 and need to meet certain criteria related to their physical activity levels. If you join the study, you'll engage in different exercise programs and help researchers learn how exercise can benefit people with MS. It's an exciting opportunity to contribute to understanding how to improve the quality of life for those living with this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • diagnosis of progressive MS by a neurologist
  • physician clearance for exercise
  • a Patient-Determined Disease Steps (PDSS) score between 3 and 7 (i.e., moderate motor disability)
  • a Timed 25-Foot Walk (T25-FW) test time \> 6.0 s.
  • Exclusion Criteria:
  • a baseline score \>24 on the Godin-Shephard Leisure Time Physical Activity Questionnaire (i.e., high physical activity levels)
  • absolute contraindications to TMS (e.g. history of seizure)
  • a history of any neurological conditions other than MS
  • relapse in the past three months (self-reported, neurologist confirmed)
  • psychiatric diagnosis
  • substance abuse

About University Of Regina

The University of Regina, a prominent Canadian institution known for its commitment to academic excellence and research innovation, serves as a clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a focus on interdisciplinary collaboration, the university leverages its diverse expertise to conduct clinical trials that address pressing health challenges and contribute to evidence-based practices. By fostering partnerships with healthcare professionals and community stakeholders, the University of Regina aims to enhance patient outcomes and promote public health through cutting-edge research and ethical trial management.

Locations

Regina, Saskatchewan, Canada

Patients applied

0 patients applied

Trial Officials

Cameron Mang, PhD

Principal Investigator

University of Regina

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials